LUT showed to be able to suppress TTR-induced toxicity in neuroblastoma cells in a cell-based viability assay with a comparable effect as diflunisal and to mediate its stabilising effect on TTR in vivo in an established D. melanogaster model of FAP. The gene discussed is TTR; the disease is neuroblastoma.